Medical and Pharmaceutical Robotic bronchoscope program reaches 100 procedures at Australian hospital The robotic system targets nodules in the outer areas of the lung, where traditional procedures can struggle to reach Joseph Morton4 days ago
Medical and Pharmaceutical New blood test approach could detect multiple cancers earlier, researchers say Scientists have long sought easier ways to identify cancer sooner Joseph MortonApril 27, 2026
Medical and Pharmaceutical Guardant Health launches multi-cancer blood test in Asia through Manulife partnership Cancer remains a leading cause of death across Asia, driving demand for early screening tools Joseph MortonMarch 18, 2026
Medical and Pharmaceutical bioAffinity launches 2,000-patient study for noninvasive lung cancer test The test analyzes sputum samples using flow cytometry to identify cancer-related cellular changes Joseph MortonMarch 11, 2026
Medical and Pharmaceutical Monash University’s medical engineering institute progresses silicosis breath test Its MedTech Commercialisation Advancement Program has been expediting the tool's development Rowan DunneMarch 9, 2026
Medical and Pharmaceutical Minnesota’s Vocxi Health and Forj Medical report success with lung cancer breath test It uses nanosensors and AI algorithms to detect volatile organic compounds linked to the disease Rowan DunneMarch 3, 2026
Medical and Pharmaceutical Olympus rolls out advanced SecureFlex EUS biopsy needle in U.S. market The SecureFlex needle supports endoscopic ultrasound-guided fine needle biopsy Joseph MortonJanuary 28, 2026
AI and Autonomy The trajectory of artificial intelligence in 2026: A Mugglehead roundup As AI moves deeper into daily life, its influence expands beyond any single product or innovation, setting the stage for broad transformation Joseph MortonDecember 24, 2025
Medical and Pharmaceutical Imperial College and Pancreatic Cancer UK begin 6,000 patient breath test study Pancreatic cancer remains one of the deadliest cancers in the UK Joseph MortonDecember 9, 2025
Medical and Pharmaceutical Exact Sciences joins Abbott, shares soar 18% on acquisition and growth prospects Abbott earned billions during the Covid-19 pandemic by selling millions of Covid tests and testing kits Joseph MortonNovember 20, 2025